EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) Stock News

TSX:EPRX - Toronto Stock Exchange - CA29842P1053 - Common Stock - Currency: CAD

7.65 -0.13 (-1.67%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EPRX.CA Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Eupraxia Pharmaceuticals Inc. - Mentions: EPRX

Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences

22 days ago - By: Eupraxia Pharmaceuticals Inc. - Mentions: EPRX

Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis

2 months ago - By: Eupraxia Pharmaceuticals Inc. - Mentions: EPRX

Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders

3 months ago - By: Eupraxia Pharmaceuticals Inc. - Mentions: EPRX

Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025

3 months ago - By: Eupraxia Pharmaceuticals Inc. - Mentions: EPRX

Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results

3 months ago - By: Eupraxia Pharmaceuticals Inc. - Mentions: EPRX

News Image

Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May

a year ago - By: Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 Million